HYGIEIA Stock

Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy.

Sign up today and learn more about HYGIEIA Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About HYGIEIA Stock

Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy. It works by guiding users to adjust their insulin doses based on changing blood glucose patterns every few days rather than three or four times annually. Its insulin guidance device replaces a patient's existing glucose meter and provides individually tailored insulin dosage recommendations between physician visits to result in the patients monitoring their diabetes levels digitally and also provides personalized adjustments to enhance and simplify it, maximizing insulin effectiveness and resulting in improved glycemic control.

Funding History

September 2008$200K
February 2010$400K
July 2011$1.5M
May 2012$145K
December 2013$1.4M
April 2015$675K
February 2017$569K
February 2018$835K
October 2018$1.3M
November 2019$1.3M
September 2020$1.7M
December 2021$17.0M
February 2023$3.3M
May 2023$5.0M

Management

Co-Founder & Clinical Research Lead

Israel Hodish

Executive Chairman

Eran Bashan

Chief Executive Officer

Doug Lawrence

COO

Hank Brown

Member of the Board

John Brooks

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo